BONRAYBIO (6955.TW) monthly revenue, September 2026

BONRAYBIO reported revenue of NT$0.03bn for September 2026, down 2.3% from the previous month and up 14.5% from a year earlier. Year-to-date revenue was NT$0.26bn, up 17.7% year on year. It ranked 66 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.

中文版

MonthRevenue NT$bnMoM %YoY %
September 20260.03-2.314.5